These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10554171)

  • 1. Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggering.
    Li N; Goodall AH; Hjemdahl P
    Cytometry; 1999 Feb; 35(2):154-61. PubMed ID: 10554171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates.
    Li N; Goodall AH; Hjemdahl P
    Br J Haematol; 1997 Dec; 99(4):808-16. PubMed ID: 9432026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A whole-blood flow cytometric assay for leukocyte CD11b expression using fluorescence signal triggering.
    Li N; Halldén G; Hjemdahl P
    Eur J Haematol; 2000 Jul; 65(1):57-65. PubMed ID: 10914940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of circulating platelet-leukocyte conjugates: a sensitive flow cytometric assay well suited for clinical studies.
    Hagberg IA; Lyberg T
    Platelets; 2000 May; 11(3):151-60. PubMed ID: 10938891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin treatment does not attenuate platelet or leukocyte activation as monitored by whole blood flow cytometry.
    Li N; Hu H; Hjemdahl P
    Thromb Res; 2003; 111(3):165-70. PubMed ID: 14678815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influences of fixatives on flow cytometric measurements of platelet P-selectin expression and fibrinogen binding.
    Hu H; Daleskog M; Li N
    Thromb Res; 2000 Nov; 100(3):161-6. PubMed ID: 11108903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of activated platelets and platelet-leukocyte aggregates in horses.
    Weiss DJ; Evanson OA
    Am J Vet Res; 1997 Aug; 58(8):823-7. PubMed ID: 9256963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The basis examination of leukocyte-platelet aggregates with CD45 gating as a novel platelet activation marker.
    Nagasawa A; Matsuno K; Tamura S; Hayasaka K; Shimizu C; Moriyama T
    Int J Lab Hematol; 2013 Oct; 35(5):534-41. PubMed ID: 23356866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric measurement of platelet-leukocyte aggregates: a possible target to monitor platelet function?
    Klinkhardt U; Harder S
    Semin Thromb Hemost; 2005; 31(4):400-3. PubMed ID: 16149016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole blood analysis of leukocyte-platelet aggregates.
    Barnard MR; Krueger LA; Frelinger AL; Furman MI; Michelson AD
    Curr Protoc Cytom; 2003 May; Chapter 6():Unit 6.15. PubMed ID: 18770779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ThromboFix platelet stabilizer: advances in clinical platelet analyses by flow cytometry?
    Schmidt V; Hilberg T
    Platelets; 2006 Jun; 17(4):266-73. PubMed ID: 16769604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro.
    Scholz T; Zhao L; Temmler U; Bath P; Heptinstall S; Lösche W
    Platelets; 2002 Nov; 13(7):401-6. PubMed ID: 12487787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological control of platelet-leukocyte interactions by the human anti-P-selectin antibody inclacumab--preclinical and clinical studies.
    Kling D; Stucki C; Kronenberg S; Tuerck D; Rhéaume E; Tardif JC; Gaudreault J; Schmitt C
    Thromb Res; 2013 May; 131(5):401-10. PubMed ID: 23522853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric analysis of circulating platelet-monocyte aggregates in whole blood: methodological considerations.
    Harding SA; Din JN; Sarma J; Jessop A; Weatherall M; Fox KA; Newby DE
    Thromb Haemost; 2007 Aug; 98(2):451-6. PubMed ID: 17721630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of platelet-leukocyte aggregates in inflammatory bowel disease.
    Irving PM; Macey MG; Shah U; Webb L; Langmead L; Rampton DS
    Inflamm Bowel Dis; 2004 Jul; 10(4):361-72. PubMed ID: 15475744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid in vitro biocompatibility assay of endovascular stents by flow cytometry using platelet activation and platelet-leukocyte aggregation.
    Tárnok A; Mahnke A; Müller M; Zotz RJ
    Cytometry; 1999 Feb; 38(1):30-9. PubMed ID: 10088974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of phosphatidylserine exposure in leukocytes and platelets by whole-blood flow cytometry with annexin V.
    Tait JF; Smith C; Wood BL
    Blood Cells Mol Dis; 1999; 25(5-6):271-8. PubMed ID: 10744422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of platelet-monocyte aggregates by the ADAM(®) image cytometer.
    Jung BK; Cho CH; Moon KC; Sung Hur D; Yoon JA; Yoon SY
    Int J Med Sci; 2014; 11(12):1228-33. PubMed ID: 25317068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of sample fixation and the use of LDS-751 or anti-CD45 for leukocyte identification in mouse whole blood for flow cytometry.
    Maes ML; Davidson LB; McDonagh PF; Ritter LS
    J Immunol Methods; 2007 Jan; 319(1-2):79-86. PubMed ID: 17187818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation and platelet-leukocyte interaction in β-thalassemia/hemoglobin E patients with marked nucleated erythrocytosis.
    Keawvichit R; Khowawisetsut L; Chaichompoo P; Polsrila K; Sukklad S; Sukapirom K; Khuhapinant A; Fucharoen S; Pattanapanyasat K
    Ann Hematol; 2012 Nov; 91(11):1685-94. PubMed ID: 22847151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.